First National Bank Sioux Falls Cuts Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

First National Bank Sioux Falls decreased its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 44.8% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,000 shares of the financial services provider’s stock after selling 1,620 shares during the quarter. First National Bank Sioux Falls’ holdings in iShares Biotechnology ETF were worth $274,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently made changes to their positions in the company. International Assets Investment Management LLC bought a new position in iShares Biotechnology ETF during the fourth quarter valued at approximately $76,425,000. Global Assets Advisory LLC bought a new position in iShares Biotechnology ETF during the first quarter valued at approximately $66,059,000. Itau Unibanco Holding S.A. bought a new position in iShares Biotechnology ETF during the third quarter valued at approximately $48,242,000. Raymond James Financial Services Advisors Inc. lifted its position in iShares Biotechnology ETF by 8.9% during the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 153,692 shares of the financial services provider’s stock valued at $20,879,000 after purchasing an additional 12,611 shares during the period. Finally, Stifel Financial Corp raised its position in iShares Biotechnology ETF by 11.7% in the fourth quarter. Stifel Financial Corp now owns 137,897 shares of the financial services provider’s stock worth $18,736,000 after acquiring an additional 14,457 shares during the period. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.0 %

Shares of IBB stock traded down $0.01 on Thursday, hitting $137.91. 971,413 shares of the stock traded hands, compared to its average volume of 1,647,499. iShares Biotechnology ETF has a 52 week low of $111.83 and a 52 week high of $141.16. The firm has a 50 day simple moving average of $133.90 and a two-hundred day simple moving average of $134.71.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.